(CAP), C. o. A. P. Protocol for the examination of specimens from patients with carcinoma of the pancreas.https://documents.cap.org/protocols/cp-gihepatobiliary-pancreas-exocrine-17protocol-4001.pdf
Adiamah, A., Arif, Z., Berti, F., Singh, S., Laskar, N., & Gomez, D. (2019). The Use of Prophylactic Somatostatin Therapy Following Pancreaticoduodenectomy: A Meta-analysis of Randomised Controlled Trials. World J Surg, 43(7), 1788-1801. https://doi.org/10.1007/s00268-019-04956-6
Adsay, V., Mino-Kenudson, M., Furukawa, T., Basturk, O., Zamboni, G., Marchegiani, G., . . . Hruban, R. H. (2016). Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting. Ann Surg, 263(1), 162-177. https://doi.org/10.1097/sla.0000000000001173
Akural, E., Ojala, R. O., Jarvimaki, V., Kariniemi, J., Tervonen, O. A., & Blanco Sequeiros, R. (2013). MR-guided Neurolytic Celiac Plexus Ablation: An Evaluation of Effects and Injection Spread Pattern in Cancer Patients with Celiac Tumor Infiltration. Cardiovasc Intervent Radiol, 36(2), 472-478. https://doi.org/10.1007/s00270-012-0417-x
Al-Hawary, M. M., Francis, I. R., Chari, S. T., Fishman, E. K., Hough, D. M., Lu, D. S., . . . Simeone, D. M. (2014). Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology, 270(1), 248-260. https://doi.org/10.1148/radiol.13131184
Allen, V. B., Gurusamy, K. S., Takwoingi, Y., Kalia, A., & Davidson, B. R. (2013). Diagnostic accuracy of laparoscopy following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer. Cochrane Database Syst Rev, (11), CD009323. https://doi.org/10.1002/14651858.CD009323.pub2
Almadi, M. A., Barkun, J. S., & Barkun, A. N. (2015). Stenting in Malignant Biliary Obstruction. Gastrointest Endosc Clin N Am, 25(4), 691-711. https://doi.org/10.1016/j.giec.2015.06.002
Alsamarrai, A., Das, S. L., Windsor, J. A., & Petrov, M. S. (2014). Factors that affect risk for pancreatic disease in the general population: a systematic review and meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol, 12(10), 1635-1644.e1635; quiz e1103. https://doi.org/10.1016/j.cgh.2014.01.038
American College of Surgeons and the Alliance for Clinical Trials in Oncology, Nelson, H., Hunt, K. K., Veeramachaneni, N., Blair, S., Chang, G., & Halverson, A. (red.). (2015). Operative Standards for Cancer Surgery: Volume 1: Breast, lung,pancreas, colon. Philadelphia: Walters Kluver.
Amin, Z., Theis, B., Russell, R. C., House, C., Novelli, M., & Lees, W. R. (2006). Diagnosing pancreatic cancer: the role of percutaneous biopsy and CT. Clin Radiol, 61(12), 996-1002.
Arcidiacono, P. G., Calori, G., Carrara, S., McNicol, E. D., & Testoni, P. A. (2011). Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev, (3), CD007519. https://doi.org/10.1002/14651858.CD007519.pub2
Arends, J., Bodoky, G., Bozzetti, F., Fearon, K., Muscaritoli, M., Selga, G., . . . Espen. (2006). ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clin Nutr, 25(2), 245-259. https://doi.org/10.1016/j.clnu.2006.01.020
Asbun, H. J., Conlon, K., Fernandez-Cruz, L., Friess, H., Shrikhande, S. V., Adham, M., . . . International Study Group of Pancreatic, S. (2014). When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery. Surgery, 155(5), 887-892. https://doi.org/10.1016/j.surg.2013.12.032
Ballehaninna, U. K., & Chamberlain, R. S. (2012). The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol, 3(2), 105-119. https://doi.org/10.3978/j.issn.2078-6891.2011.021
Bassi, C., Dervenis, C., Butturini, G., Fingerhut, A., Yeo, C., Izbicki, J., . . . International Study Group on Pancreatic Fistula, D. (2005). Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery, 138(1), 8-13.
Basturk, O., Hong, S. M., Wood, L. D., Adsay, N. V., Albores-Saavedra, J., Biankin, A. V., . . . Furukawa, T. (2015). A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol, 39(12), 1730-1741. https://doi.org/10.1097/pas.0000000000000533
Ben, Q., Xu, M., Ning, X., Liu, J., Hong, S., Huang, W., . . . Li, Z. (2011). Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies. Eur J Cancer, 47(13), 1928-1937. https://doi.org/10.1016/j.ejca.2011.03.003
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Tomlinson, J. S., Stewart, A. K., Winchester, D. P., & Talamonti, M. S. (2007). Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Cancer, 110(6), 1227-1234.
Bjerregaard, J. K., Mortensen, M. B., Schonnemann, K. R., & Pfeiffer, P. (2013). Characteristics, therapy and outcome in an unselected and prospectively registered cohort of pancreatic cancer patients. Eur J Cancer, 49(1), 98-105. https://doi.org/10.1016/j.ejca.2012.07.017
Bockhorn, M., Uzunoglu, F. G., Adham, M., Imrie, C., Milicevic, M., Sandberg, A. A., . . . Izbicki, J. R. (2014). Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery, 155(6), 977-988. https://doi.org/10.1016/j.surg.2014.02.001
Bond-Smith, G., Banga, N., Hammond, T. M., & Imber, C. J. (2012). Pancreatic adenocarcinoma. Bmj, 344, e2476. https://doi.org/10.1136/bmj.e2476
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 68(6), 394-424. https://doi.org/10.3322/caac.21492
Brennan, M. F., Pisters, P. W., Posner, M., Quesada, O., & Shike, M. (1994). A prospective randomized trial of total parenteral nutrition after major pancreatic resection for malignancy. Ann Surg, 220(4), 436-441.
Brugge, W., Dewitt, J., Klapman, J. B., Ashfaq, R., Shidham, V., Chhieng, D., . . . Staerkel, G. (2014). Techniques for cytologic sampling of pancreatic and bile duct lesions. Diagn Cytopathol, 42(4), 333-337. https://doi.org/10.1002/dc.23096
Burris, H., & Storniolo, A. M. (1997). Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur J Cancer, 33(Suppl 1), S18-S22.
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., . . . Von Hoff, D. D. (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15(6), 2403-2413.
Callery, M. P., Chang, K. J., Fishman, E. K., Talamonti, M. S., William Traverso, L., & Linehan, D. C. (2009). Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol, 16(7), 1727-1733. https://doi.org/10.1245/s10434-009-0408-6
Campell, F., & Verbeke, C. S. (2013). Pathology of the pancreas: a practical approach. London: Springer.
Carioli, G., Bertuccio, P., Boffetta, P., Levi, F., La Vecchia, C., Negri, E., & Malvezzi, M. (2020). European cancer mortality predictions for the year 2020 with a focus on prostate cancer. Ann Oncol, 31(5), 650-658. https://doi.org/10.1016/j.annonc.2020.02.009
Cascinu, S., Falconi, M., Valentini, V., & Jelic, S. (2010). Pancreatic cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 21(Suppl 5), v55-58. https://doi.org/10.1093/annonc/mdq165
Chandrasegaram, M. D., Goldstein, D., Simes, J., Gebski, V., Kench, J. G., Gill, A. J., . . . Barbour, A. P. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. Br J Surg, 102(12), 1459-1472. https://doi.org/10.1002/bjs.9892
Christians, K. K., Tsai, S., Tolat, P. P., & Evans, D. B. (2013). Critical steps for pancreaticoduodenectomy in the setting of pancreatic adenocarcinoma. J Surg Oncol, 107(1), 33-38. https://doi.org/10.1002/jso.23166
Cloyd, J. M., Shen, C., Santry, H., Bridges, J., Dillhoff, M., Ejaz, A., . . . Tsung, A. (2020). Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma. J Natl Compr Canc Netw, 18(5), 556-563. https://doi.org/10.6004/jnccn.2019.7380
Conrad, C., & Lillemoe, K. D. (2012). Surgical palliation of pancreatic cancer. Cancer J, 18(6), 577-583. https://doi.org/10.1097/PPO.0b013e3182797dfe
Conroy, T., Desseigne, F., Ychou, M., Bouche, O., Guimbaud, R., Becouarn, Y., . . . Ducreux, M. (2011). FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med, 364(19), 1817-1825.
Conroy, T., Hammel, P., Hebbar, M., Ben Abdelghani, M., Wei, A. C., Raoul, J. L., . . . the Unicancer, G. I. P. G. (2018). FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer. N Engl J Med, 379(25), 2395-2406. https://doi.org/10.1056/NEJMoa1809775
Correa-Gallego, C., Brennan, M., FD'Angelica, M., IDeMatteo, R., PFong, YKingham, T., . . . Allen, P. J. (2012). Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011. J Am Coll Surg, 215(5), 616-621. https://doi.org/10.1016/j.jamcollsurg.2012.07.010
Costamagna, G., & Pandolfi, M. (2004). Endoscopic stenting for biliary and pancreatic malignancies. J Clin Gastroenterol, 38(1), 59-67.
Cote, G. A., & Sherman, S. (2010). Advances in pancreatobiliary endoscopy. Curr Opin Gastroenterol, 26(5), 429-435. https://doi.org/10.1097/MOG.0b013e32833d171f
Datta, J., & Vollmer, C. M., Jr. (2016). Advances in Surgical Management of Pancreatic Diseases. Gastroenterol Clin North Am, 45(1), 129-144. https://doi.org/10.1016/j.gtc.2015.10.002
Del Chiaro, M., Verbeke, C., Salvia, R., Kloppel, G., Werner, J., McKay, C., . . . Segersvard, R. (2013). European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis, 45(9), 703-711. https://doi.org/10.1016/j.dld.2013.01.010
Dennis, J. L., Hvidsten, T. R., Wit, E. C., Komorowski, J., Bell, A. K., Downie, I., . . . Oien, K. A. (2005). Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res, 11(10), 3766-3772. https://doi.org/10.1158/1078-0432.CCR-04-2236
Deshpande, V., Konstantinidis, I. T., Castillo, C. F., Hezel, A. F., Haigis, K. M., Ting, D. T., . . . Ferrone, C. R. (2016). Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma. J Gastrointest Surg, 20(5), 953-959. https://doi.org/10.1007/s11605-016-3108-0
Diener, M. K., Mehr, K. T., Wente, M. N., Kieser, M., Buchler, M. W., & Seiler, C. M. (2011). Risk-benefit assessment of closed intra-abdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing the current state of evidence. Langenbecks Arch Surg, 396(1), 41-52. https://doi.org/10.1007/s00423-010-0716-0
Dimarco, M., Cannella, R., Pellegrino, S., Iadicola, D., Tutino, R., Allegra, F., . . . Vernuccio, F. (2020). Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability. Abdom Radiol (NY), 45(2), 437-448. https://doi.org/10.1007/s00261-019-02287-7
Ducreux, M., Cuhna, A. S., Caramella, C., Hollebecque, A., Burtin, P., Goere, D., . . . Committee, E. G. (2015). Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 26 Suppl 5, v56-68. https://doi.org/10.1093/annonc/mdv295
Dudekula, A., Munigala, S., Zureikat, A. H., & Yadav, D. (2016). Operative Trends for Pancreatic Diseases in the USA: Analysis of the Nationwide Inpatient Sample from 1998-2011. J Gastrointest Surg, 20(4), 803-811. https://doi.org/10.1007/s11605-015-3067-x
Dumonceau, J. M., Deprez, P. H., Jenssen, C., Iglesias-Garcia, J., Larghi, A., Vanbiervliet, G., . . . Polkowski, M. (2017). Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated January 2017. Endoscopy, 49(7), 695-714. https://doi.org/10.1055/s-0043-109021
Dumonceau, J. M., Tringali, A., Papanikolaou, I. S., Blero, D., Mangiavillano, B., Schmidt, A., . . . van Hooft, J. E. (2018). Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline - Updated October 2017. Endoscopy, 50(9), 910-930. https://doi.org/10.1055/a-0659-9864
Dy, S. M. (2006). Enteral and parenteral nutrition in terminally ill cancer patients: a review of the literature. Am J Hosp Palliat Care, 23(5), 369-377. https://doi.org/10.1177/1049909106292167
Daamen, L. A., Groot, V. P., Intven, M. P. W., Besselink, M. G., Busch, O. R., Koerkamp, B. G., . . . Dutch Pancreatic Cancer, G. (2019). Postoperative surveillance of pancreatic cancer patients. Eur J Surg Oncol, 45(10), 1770-1777. https://doi.org/10.1016/j.ejso.2019.05.031
Eeson, G., Chang, N., McGahan, C. E., Khurshed, F., Buczkowski, A. K., Scudamore, C. H., . . . Chung, S. W. (2012). Determination of factors predictive of outcome for patients undergoing a pancreaticoduodenectomy of pancreatic head ductal adenocarcinomas. HPB (Oxford), 14(5), 310-316. https://doi.org/10.1111/j.1477-2574.2012.00448.x
Fattahi, R., Balci, N. C., Perman, W. H., Hsueh, E. C., Alkaade, S., Havlioglu, N., & Burton, F. R. (2009). Pancreatic diffusion-weighted imaging (DWI): comparison between mass-forming focal pancreatitis (FP), pancreatic cancer (PC), and normal pancreas. J Magn Reson Imaging, 29(2), 350-356. https://doi.org/10.1002/jmri.21651
Fearon, K., Strasser, F., Anker, S. D., Bosaeus, I., Bruera, E., Fainsinger, R. L., . . . Baracos, V. E. (2011). Definition and classification of cancer cachexia: an international consensus. Lancet Oncol, 12(5), 489-495.
Ferrone, C. R., Marchegiani, G., Hong, T. S., Ryan, D. P., Deshpande, V., McDonnell, E. I., . . . Fernandez-del Castillo, C. (2015). Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer. Ann Surg, 261(1), 12-17. https://doi.org/10.1097/SLA.0000000000000867
Fong, Z. V., Ferrone, C. R., Lillemoe, K. D., & Fernandez-Del Castillo, C. (2016). Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies. Ann Surg, 263(5), 908-917. https://doi.org/10.1097/sla.0000000000001567
Fusaroli, P., Kypraios, D., Eloubeidi, M. A., & Caletti, G. (2012). Levels of evidence in endoscopic ultrasonography: a systematic review. Dig Dis Sci, 57(3), 602-609. https://doi.org/10.1007/s10620-011-1961-y
Garcea, G., Cairns, V., Berry, D. P., Neal, C. P., Metcalfe, M. S., & Dennison, A. R. (2012). Improving the diagnostic yield from staging laparoscopy for periampullary malignancies: the value of preoperative inflammatory markers and radiological tumor size. Pancreas, 41(2), 233-237. https://doi.org/10.1097/MPA.0b013e31822432ee
Genkinger, J. M., Kitahara, C. M., Bernstein, L., Berrington de Gonzalez, A., Brotzman, M., Elena, J. W., . . . Jacobs, E. J. (2015). Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Ann Oncol, 26(11), 2257-2266. https://doi.org/10.1093/annonc/mdv355
George, E., Wortman, J. R., Fulwadhva, U. P., Uyeda, J. W., & Sodickson, A. D. (2017). Dual energy CT applications in pancreatic pathologies. Br J Radiol, 90(1080), 20170411. https://doi.org/10.1259/bjr.20170411
Ghaneh, P., Costello, E., & Neoptolemos, J. P. (2007). Biology and management of pancreatic cancer. Gut, 56(8), 1134-1152.
Gianotti, L., Besselink, M. G., Sandini, M., Hackert, T., Conlon, K., Gerritsen, A., . . . Bassi, C. (2018). Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 164(5), 1035-1048. https://doi.org/10.1016/j.surg.2018.05.040
Gill;A.J., & Lam;A.K. (2019). Tumours of the pancreas. Lyon, France: IACR.
Gillen, S., Schuster, T., Friess, H., & Kleeff, J. (2012). Palliative resections versus palliative bypass procedures in pancreatic cancer—a systematic review. Am J Surg, 203(4), 496-502.
Glimelius, B., Hoffman, K., Graf, W., Haglund, U., Nyren, O., Pahlman, L., & Sjoden, P. O. (1995). Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol, 6(3), 267-274.
Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., . . . International Cancer of the Pancreas Screening, c. (2020). Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. Gut, 69(1), 7-17. https://doi.org/10.1136/gutjnl-2019-319352
Good, P., Cavenagh, J., Mather, M., & Ravenscroft, P. (2008). Medically assisted nutrition for palliative care in adult patients. Cochrane Database Syst Rev, (4), CD006274. https://doi.org/10.1002/14651858.CD006274.pub2
Gounaris, I., Zaki, K., & Corrie, P. (2010). Options for the treatment of gemcitabine-resistant advanced pancreatic cancer. JOP, 11(2), 113-123.
Gress, F., Schmitt, C., Sherman, S., Ikenberry, S., & Lehman, G. (1999). A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol, 94(4), 900-905.
Groot, V. P., Gemenetzis, G., Blair, A. B., Rivero-Soto, R. J., Yu, J., Javed, A. A., . . . He, J. (2019). Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma. Ann Surg, 269(6), 1154-1162. https://doi.org/10.1097/SLA.0000000000002734
Gärtner, S., Kruger, J., Aghdassi, A. A., Steveling, A., Simon, P., Lerch, M. M., & Mayerle, J. (2016). Nutrition in Pancreatic Cancer: A Review. Gastrointest Tumors, 2(4), 195-202. https://doi.org/10.1159/000442873
Hartwig, W., Strobel, O., Hinz, U., Fritz, S., Hackert, T., Roth, C., . . . Werner, J. (2013). CA19-9 in potentially resectable pancreatic cancer: perspective to adjust surgical and perioperative therapy. Ann Surg Oncol, 20(7), 2188-2196. https://doi.org/10.1245/s10434-012-2809-1
He, J., Ahuja, N., Makary, M. A., Cameron, J. L., Eckhauser, F. E., Choti, M. A., . . . Wolfgang, C. L. (2014). 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford), 16(1), 83-90. https://doi.org/10.1111/hpb.12078
He, J., Schulick, R. D., & Del Chiaro, M. (2021). Landmark Series: Neoadjuvant Treatment in Borderline Resectable Pancreatic Cancer. Ann Surg Oncol. https://doi.org/10.1245/s10434-020-09535-x
Helsedirektoratet. (2020). Antibiotika i sykehus. Nasjonal faglig retnignslinje.: Helsedirektoratet.
Hewitt, M. J., McPhail, M. J., Possamai, L., Dhar, A., Vlavianos, P., & Monahan, K. J. (2012). EUS-guided FNA for diagnosis of solid pancreatic neoplasms: a meta-analysis. Gastrointest Endosc, 75(2), 319-331. https://doi.org/10.1016/j.gie.2011.08.049
Hidalgo, M. (2010). Pancreatic cancer. N Engl J Med, 362(17), 1605-1617.
Hidalgo, M., Cascinu, S., Kleeff, J., Labianca, R., Lohr, J. M., Neoptolemos, J., . . . Heinemann, V. (2015). Addressing the challenges of pancreatic cancer: future directions for improving outcomes. Pancreatology, 15(1), 8-18. https://doi.org/10.1016/j.pan.2014.10.001
Hoem, D., & Viste, A. (2012). Improving survival following surgery for pancreatic ductal adenocarcinoma--a ten-year experience. Eur J Surg Oncol, 38(3), 245-251. https://doi.org/10.1016/j.ejso.2011.12.010
Horton, K. M., & Fishman, E. K. (2002). Multidetector CT angiography of pancreatic carcinoma: part 2, evaluation of venous involvement. AJR Am J Roentgenol, 178(4), 833-836.
Hruban, R. H., & Klimstra, D. S. (2014). Adenocarcinoma of the pancreas. Semin Diagn Pathol, 31(6), 443-451. https://doi.org/10.1053/j.semdp.2014.08.004
Huang, L., Jansen, L., Balavarca, Y., Babaei, M., van der Geest, L., Lemmens, V., . . . Brenner, H. (2018). Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study. BMC Med, 16(1), 125. https://doi.org/10.1186/s12916-018-1120-9
Huang, L., Jansen, L., Balavarca, Y., Molina-Montes, E., Babaei, M., van der Geest, L., . . . Brenner, H. (2019). Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. Gut, 68(1), 130-139. https://doi.org/10.1136/gutjnl-2017-314828
Huttner, F. J., Fitzmaurice, C., Schwarzer, G., Seiler, C. M., Antes, G., Buchler, M. W., & Diener, M. K. (2016). Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev, (2), CD006053. https://doi.org/10.1002/14651858.CD006053.pub6
Isaji, S., Mizuno, S., Windsor, J. A., Bassi, C., Fernandez-Del Castillo, C., Hackert, T., . . . Wolfgang, C. L. (2018). International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology, 18(1), 2-11. https://doi.org/10.1016/j.pan.2017.11.011
Kambadakone, A., Thabet, A., Gervais, D. A., Mueller, P. R., & Arellano, R. S. (2011). CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics, 31(6), 1599-1621.
Kamisawa, T., Wood, L. D., Itoi, T., & Takaori, K. (2016). Pancreatic cancer. Lancet, 388(10039), 73-85. https://doi.org/10.1016/s0140-6736(16)00141-0
Katz, M. H., Fleming, J. B., Bhosale, P., Varadhachary, G., Lee, J. E., Wolff, R., . . . Balachandran, A. (2012). Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer, 118(23), 5749-5756. https://doi.org/10.1002/cncr.27636 [doi]
Katz, M. H., Varadhachary, G. R., Fleming, J. B., Wolff, R. A., Lee, J. E., Pisters, P. W., . . . Evans, D. B. (2010). Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation. Ann Surg Oncol, 17(7), 1794-1801. https://doi.org/10.1245/s10434-010-0943-1
Kawai, M., Tani, M., Terasawa, H., Ina, S., Hirono, S., Nishioka, R., . . . Yamaue, H. (2006). Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg, 244(1), 1-7.
Kim, J. H., Park, S. H., Yu, E. S., Kim, M. H., Kim, J., Byun, J. H., . . . Lee, M. G. (2010). Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology, 257(1), 87-96.
Kleive, D., Labori, K. J., Line, P. D., Gladhaug, I. P., & Verbeke, C. S. (2020). Pancreatoduodenectomy with venous resection for ductal adenocarcinoma rarely achieves complete (R0) resection. HPB (Oxford), 22(1), 50-57. https://doi.org/10.1016/j.hpb.2019.05.005
Kleive, D., Sahakyan, M. A., Berstad, A. E., Verbeke, C. S., Gladhaug, I. P., Edwin, B., . . . Labori, K. J. (2017). Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. Br J Surg, 104(11), 1558-1567. https://doi.org/10.1002/bjs.10603
Kleive, D., Sahakyan, M. A., Khan, A., Fosby, B., Line, P. D., & Labori, K. J. (2018). Incidence and management of arterial injuries during pancreatectomy. Langenbecks Arch Surg, 403(3), 341-348. https://doi.org/10.1007/s00423-018-1666-1
Klompmaker, S., van Hilst, J., Gerritsen, S. L., Adham, M., Teresa Albiol Quer, M., Bassi, C., . . . group, E. A. D.-C. s. (2018). Outcomes After Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Cancer: A Pan-European Retrospective Cohort Study. Ann Surg Oncol, 25(5), 1440-1447. https://doi.org/10.1245/s10434-018-6391-z
Kneuertz, P. J., Cunningham, S. C., Cameron, J. L., Torrez, S., Tapazoglou, N., Herman, J. M., . . . Pawlik, T. M. (2011). Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience. J Gastrointest Surg, 15(11), 1917-1927. https://doi.org/10.1007/s11605-011-1665-9
Kunstman, J. W., Fonseca, A. L., Ciarleglio, M. M., Cong, X., Hochberg, A., & Salem, R. R. (2012). Comprehensive analysis of variables affecting delayed gastric emptying following pancreaticoduodenectomy. J Gastrointest Surg, 16(7), 1354-1361. https://doi.org/10.1007/s11605-012-1873-y
Labori, K. J., Katz, M. H., Tzeng, C. W., Bjornbeth, B. A., Cvancarova, M., Edwin, B., . . . Gladhaug, I. P. (2016). Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study. Acta Oncol, 55(3), 265-277. https://doi.org/10.3109/0284186X.2015.1068445
Labori, K. J., Kleive, D., Khan, A., Farnes, I., Fosby, B., & Line, P. D. (2020). Graft type for superior mesenteric and portal vein reconstruction in pancreatic surgery - A systematic review. HPB (Oxford). https://doi.org/10.1016/j.hpb.2020.11.008
Labori, K. J., Lassen, K., Hoem, D., Gronbech, J. E., Soreide, J. A., Mortensen, K., . . . Dueland, S. (2017). Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial. BMC Surg, 17(1), 94. https://doi.org/10.1186/s12893-017-0291-1
Labori, K. J., Verbeke, C. S., & Gladhaug, I. P. (2015). Information needs among patients and a surveillance strategy after surgery for pancreatic and periampullary cancer. HPB (Oxford), 17(7), 659. https://doi.org/10.1111/hpb.12411
Larssen, L., Medhus, A. W., & Hauge, T. (2009). Treatment of malignant gastric outlet obstruction with stents: an evaluation of the reported variables for clinical outcome. BMC Gastroenterol, 9, 45.
Lassen, K., Kjaeve, J., Fetveit, T., Trano, G., Sigurdsson, H. K., Horn, A., & Revhaug, A. (2008). Allowing normal food at will after major upper gastrointestinal surgery does not increase morbidity: a randomized multicenter trial. Ann Surg, 247(5), 721-729. https://doi.org/10.1097/SLA.0b013e31815cca68
Laurence, J. M., Tran, P. D., Morarji, K., Eslick, G. D., Lam, V. W., & Sandroussi, C. (2011). A systematic review and meta-analysis of survival and surgical outcomes following neoadjuvant chemoradiotherapy for pancreatic cancer. J Gastrointest Surg, 15(11), 2059-2069. https://doi.org/10.1007/s11605-011-1659-7
Leach, S. D., Lee, J. E., Charnsangavej, C., Cleary, K. R., Lowy, A. M., Fenoglio, C. J., . . . Evans, D. B. (1998). Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head. Br J Surg, 85(5), 611-617.
Lee, T. Y., Kim, M. H., Park do, H., Seo, D. W., Lee, S. K., Kim, J. S., & Lee, K. T. (2009). Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol, 193(2), 343-348.
Lillemoe, K. D., Cameron, J. L., Kaufman, H. S., Yeo, C. J., Pitt, H. A., & Sauter, P. K. (1993). Chemical splanchnicectomy in patients with unresectable pancreatic cancer. A prospective randomized trial. Ann Surg, 217(5), 447-455.
Liu, H., Shi, J., Anandan, V., Wang, H. L., Diehl, D., Blansfield, J., . . . Lin, F. (2012). Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas. Arch Pathol Lab Med, 136(6), 601-609. https://doi.org/10.5858/arpa.2011-0326-OA
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., . . . Bast, R. C. (2006). ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol, 24(33), 5313-5327.
Lov om kommunale helse- og omsorgstjenester m.m. (helse- og omsorgstjenesteloven). LOV-2011-06-24-30.
Low, G., Panu, A., Millo, N., & Leen, E. (2011). Multimodality imaging of neoplastic and nonneoplastic solid lesions of the pancreas. Radiographics, 31(4), 993-1015. https://doi.org/10.1148/rg.314105731
Madhoun, M. F., Wani, S. B., Rastogi, A., Early, D., Gaddam, S., Tierney, W. M., & Maple, J. T. (2013). The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy, 45(2), 86-92. https://doi.org/10.1055/s-0032-1325992
Maggino, L., Malleo, G., Marchegiani, G., Viviani, E., Nessi, C., Ciprani, D., . . . Salvia, R. (2019). Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma. JAMA Surg, 154(10), 932-942. https://doi.org/10.1001/jamasurg.2019.2277
Maillette de Buy Wenniger, L., Rauws, E. A., & Beuers, U. (2012). What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree. Endoscopy, 44(1), 66-73. https://doi.org/10.1055/s-0031-1291540
Majumder, S., Chubineh, S., & Birk, J. (2012). Pancreatic cancer: an endoscopic perspective. Expert Rev Gastroenterol Hepatol, 6(1), 95-103. https://doi.org/10.1586/egh.11.93
Mansfield, S. D., Sen, G., Oppong, K., Jacques, B. C., O'Suilleabhain, C. B., Manas, D. M., & Charnley, R. M. (2006). Increase in serum bilirubin levels in obstructive jaundice secondary to pancreatic and periampullary malignancy--implications for timing of resectional surgery and use of biliary drainage. HPB (Oxford), 8(6), 442-445. https://doi.org/10.1080/13651820600919860
Manzelli, A., Petrou, A., Lazzaro, A., Brennan, N., Soonawalla, Z., & Friend, P. (2011). Groove pancreatitis. A mini-series report and review of the literature. JOP, 12(3), 230-233.
https://pubmed.ncbi.nlm.nih.gov/21546697/
Marangoni, G., Morris-Stiff, G., Deshmukh, S., Hakeem, A., & Smith, A. M. (2012). A modern approach to teaching pancreatic surgery: stepwise pancreatoduodenectomy for trainees. J Gastrointest Surg, 16(8), 1597-1604. https://doi.org/10.1007/s11605-012-1934-2
Matthaei, H., Hong, S. M., Mayo, S. C., dal Molin, M., Olino, K., Venkat, R., . . . Hruban, R. H. (2011). Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol, 18(12), 3493-3499. https://doi.org/10.1245/s10434-011-1745-9
Mayo, S. C., Austin, D. F., Sheppard, B. C., Mori, M., Shipley, D. K., & Billingsley, K. G. (2009). Evolving preoperative evaluation of patients with pancreatic cancer: does laparoscopy have a role in the current era? J Am Coll Surg, 208(1), 87-95.
McQuay, H. J., Collins, S. L., Carroll, D., & Moore, R. A. (2000). Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev, (2), CD001793. https://doi.org/10.1002/14651858.CD001793
Melloul, E., Lassen, K., Roulin, D., Grass, F., Perinel, J., Adham, M., . . . Demartines, N. (2020). Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019. World J Surg, 44(7), 2056-2084. https://doi.org/10.1007/s00268-020-05462-w
Michalski, C. W., Kleeff, J., Wente, M. N., Diener, M. K., Buchler, M. W., & Friess, H. (2007). Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg, 94(3), 265-273.
Michl, P., & Gress, T. M. (2013). Current concepts and novel targets in advanced pancreatic cancer. Gut, 62(2), 317-326. https://doi.org/10.1136/gutjnl-2012-303588
Michl, P., Pauls, S., & Gress, T. M. (2006). Evidence-based diagnosis and staging of pancreatic cancer. Best Pract Res Clin Gastroenterol, 20(2), 227-251. https://doi.org/10.1016/j.bpg.2005.10.005
Molina-Montes, E., Coscia, C., Gomez-Rubio, P., Fernandez, A., Boenink, R., Rava, M., . . . PanGen, E. U. S. I. (2020). Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. Gut. https://doi.org/10.1136/gutjnl-2019-319990
Mollberg, N., Rahbari, N. N., Koch, M., Hartwig, W., Hoeger, Y., Buchler, M. W., & Weitz, J. (2011). Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg, 254(6), 882-893. https://doi.org/10.1097/SLA.0b013e31823ac299
Moon, S. H., & Kim, M. H. (2012). The role of endoscopy in the diagnosis of autoimmune pancreatitis. Gastrointest Endosc, 76(3), 645-656. https://doi.org/10.1016/j.gie.2012.04.458
Moon, S. H., Kim, M. H., Park, D. H., Hwang, C. Y., Park, S. J., Lee, S. S., . . . Lee, S. K. (2008). Is a 2-week steroid trial after initial negative investigation for malignancy useful in differentiating autoimmune pancreatitis from pancreatic cancer? A prospective outcome study. Gut, 57(12), 1704-1712. https://doi.org/10.1136/gut.2008.150979
Mukherjee, S., Hurt, C. N., Bridgewater, J., Falk, S., Cummins, S., Wasan, H., . . . Maughan, T. (2013). Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial. Lancet Oncol, 14(4), 317-326. https://doi.org/10.1016/S1470-2045(13)70021-4
Nasjonal helseplan (2007-2010). (2006). (Særtrykk av St.prp. nr. 1 (2006-2007) kapittel 6). Oslo: Helse- og omsorgsdepartementet. Hentet fra http://www.regjeringen.no/upload/HOD/Sykehus/Nasjonal_helseplan_Sartrykk.pdf
Nasjonal strategi for kreftområdet 2006-2009. (2006). Oslo: Helse- og omsorgsdepartementet. Hentet fra https://www.regjeringen.no/globalassets/upload/hod/sykehus/kreftstrategi-2006-2009.pdf
Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av nevroendokrine svulster i fordøyelsessystemet. (2020). (Vol. IS-2946): Helsedirektoratet.
Nasjonalt handlingsprogram med retningslinjer for palliasjon i kreftomsorgen. (2014). Oslo: Helsedirektoratet. Hentet fra https://helsedirektoratet.no/retningslinjer/nasjonalt-handlingsprogram-med-retningslinjer-for-palliasjon-i-kreftomsorgen
Neoptolemos, J. P., Palmer, D. H., Ghaneh, P., Psarelli, E. E., Valle, J. W., Halloran, C. M., . . . Buchler, M. W. (2017). Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389(10073), 1011-1024. https://doi.org/10.1016/s0140-6736(16)32409-6
Neoptolemos, J. P., Stocken, D. D., Bassi, C., Ghaneh, P., Cunningham, D., Goldstein, D., . . . Buchler, M. W. (2010). Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA, 304(10), 1073-1081.
Neoptolemos, J. P., Stocken, D. D., Friess, H., Bassi, C., Dunn, J. A., Hickey, H., . . . Buchler, M. W. (2004). A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med, 350(12), 1200-1210.
Network, N. C. C. (2015). Practice Guidelines in Oncology:Pancreatic adenocarcinoma V1.2020.
NGICG-HPB. Retningslinjer for utredning, behandling og kontroll av cystiske pancreaslesjoner. fra https://ngicg.no/handlingsprogram/retningslinjer
Nordøy, T., Thoresen, L., Kvikstad, A., & Svensen, R. (2006). Ernæring og væskebehandling til pasienter med ikke-kurabel kreftsykdom. Tidsskr Nor Lægeforen, 126(5), 624-627.
Norway, C. R. o. Cancer in Norway 2018. Cancer incidence, mortality, survival and prevalence in Norway.
Nymo, L. S., Kleive, D., Waardal, K., Bringeland, E. A., Soreide, J. A., Labori, K. J., . . . Lassen, K. (2020). Centralizing a national pancreatoduodenectomy service: striking the right balance. BJS Open. https://doi.org/10.1002/bjs5.50342
Oettle, H., Post, S., Neuhaus, P., Gellert, K., Langrehr, J., Ridwelski, K., . . . Riess, H. (2007). Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA, 297(3), 267-277.
Palmer, K. R., Kerr, M., Knowles, G., Cull, A., Carter, D. C., & Leonard, R. C. (1994). Chemotherapy prolongs survival in inoperable pancreatic carcinoma. Br J Surg, 81(6), 882-885.
Peters, M. L., Tseng, J. F., & Miksad, R. A. (2016). Genetic Testing in Pancreatic Ductal Adenocarcinoma: Implications for Prevention and Treatment. Clin Ther, 38(7), 1622-1635. https://doi.org/10.1016/j.clinthera.2016.03.006
Petrucciani, N., Nigri, G., Debs, T., Giannini, G., Sborlini, E., Antolino, L., . . . Ramacciato, G. (2016). Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: Does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology, 16(6), 1037-1043. https://doi.org/10.1016/j.pan.2016.09.004
Plonk, W. M., & Arnold, R. M. (2005). Terminal care: the last weeks of life. J Palliat Med, 8(5), 1042-1054. https://doi.org/10.1089/jpm.2005.8.1042
Rebours, V., Levy, P., & Ruszniewski, P. (2012). An overview of hereditary pancreatitis. Dig Liver Dis, 44(1), 8-15. https://doi.org/10.1016/j.dld.2011.08.003
Sabater, L., Ausania, F., Bakker, O. J., Boadas, J., Dominguez-Munoz, J. E., Falconi, M., . . . de-Madaria, E. (2016). Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery. Ann Surg, 264(6), 949-958. https://doi.org/10.1097/SLA.0000000000001732
Schima, W., Ba-Ssalamah, A., Goetzinger, P., Scharitzer, M., & Koelblinger, C. (2007). State-of-the-art magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging, 18(6), 421-429. https://doi.org/10.1097/rmr.0b013e31816459e0
Schmidt-Hansen, M., Berendse, S., & Hamilton, W. (2016). Symptoms of Pancreatic Cancer in Primary Care: A Systematic Review. Pancreas, 45(6), 814-818. https://doi.org/10.1097/mpa.0000000000000527
Shimosegawa, T., Chari, S. T., Frulloni, L., Kamisawa, T., Kawa, S., Mino-Kenudson, M., . . . International Association of, P. (2011). International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas, 40(3), 352-358. https://doi.org/10.1097/MPA.0b013e3182142fd2
Simianu, V. V., Zyromski, N. J., Nakeeb, A., & Lillemoe, K. D. (2010). Pancreatic cancer: progress made. Acta Oncol, 49(4), 407-417. https://doi.org/10.3109/02841860903447051
Slaar, A., Eshuis, W. J., van der Gaag, N. A., Nio, C. Y., Busch, O. R., van Gulik, T. M., . . . Gouma, D. J. (2011). Predicting distant metastasis in patients with suspected pancreatic and periampullary tumors for selective use of staging laparoscopy. World J Surg, 35(11), 2528-2534.
Sohal, D. P. S., Duong, M., Ahmad, S. A., Gandhi, N. S., Beg, M. S., Wang-Gillam, A., . . . Hochster, H. S. (2021). Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. https://doi.org/10.1001/jamaoncol.2020.7328
Solomon, S., & Whitcomb, D. C. (2012). Genetics of Pancreatitis: An Update for Clinicians and Genetic Counselors. Curr Gastroenterol Rep, 14(2), 112-117. https://doi.org/10.1007/s11894-012-0240-1
Stewart, G. D., Skipworth, R. J., & Fearon, K. C. (2006). Cancer cachexia and fatigue. Clin Med, 6(2), 140-143.
Strong, V. E., Dalal, K. M., Malhotra, V. T., Cubert, K. H., Coit, D., Fong, Y., & Allen, P. J. (2006). Initial report of laparoscopic celiac plexus block for pain relief in patients with unresectable pancreatic cancer. J Am Coll Surg, 203(1), 129-131.
Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L., Burt, R. W., & American College of, G. (2015). ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol, 110(2), 223-262; quiz 263. https://doi.org/10.1038/ajg.2014.435
Sze, W. M., Shelley, M., Held, I., & Mason, M. (2004). Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. Cochrane Database Syst Rev, (2), CD004721. https://doi.org/10.1002/14651858.CD004721
Søreide, J. A., Sandvik, O. M., & Søreide, K. (2016). Improving pancreas surgery over time: Performance factors related to transition of care and patient volume. Int J Surg, 32, 116-122. https://doi.org/10.1016/j.ijsu.2016.06.046
Søreide, K., & Labori, K. J. (2016). Risk factors and preventive strategies for post-operative pancreatic fistula after pancreatic surgery: a comprehensive review. Scand J Gastroenterol, 51(10), 1147-1154. https://doi.org/10.3109/00365521.2016.1169317
Søreide, K., Aagnes, B., Møller, B., Westgaard, A., & Bray, F. (2010). Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965-2007. Scand J Gastroenterol, 45(1), 82-92.
Takuma, K., Kamisawa, T., Gopalakrishna, R., Hara, S., Tabata, T., Inaba, Y., . . . Igarashi, Y. (2012). Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol, 18(10), 1015-1020.
Templeton, A. W., & Brentnall, T. A. (2013). Screening and surgical outcomes of familial pancreatic cancer. Surgical Clinics of North America, 93(3), 629-645.
TNM Classification of Malignant Tumours, 8th Edition. (2017). (8. utg.). Oxford: Wiley-Blackwell.
Tol, J. A., Gouma, D. J., Bassi, C., Dervenis, C., Montorsi, M., Adham, M., . . . Charnley, R. M. (2014). Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery, 156(3), 591-600. https://doi.org/10.1016/j.surg.2014.06.016
Tol, J. A., van Gulik, T. M., Busch, O. R., & Gouma, D. J. (2012). Centralization of highly complex low-volume procedures in upper gastrointestinal surgery. A summary of systematic reviews and meta-analyses. Dig Surg, 29(5), 374-383. https://doi.org/10.1159/000343929
Tol, J. A., van Hooft, J. E., Timmer, R., Kubben, F. J., van der Harst, E., de Hingh, I. H., . . . Gouma, D. J. (2015). Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer. Gut. https://doi.org/10.1136/gutjnl-2014-308762
Traverso, L. W., & Longmire, W. P. (1978). Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet, 146(6), 959-962.
Tseng, J. F., Raut, C. P., Lee, J. E., Pisters, P. W., Vauthey, J. N., Abdalla, E. K., . . . Evans, D. B. (2004). Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg, 8(8), 935-949. https://doi.org/10.1016/j.gassur.2004.09.046
Tzeng, C. W., Fleming, J. B., Lee, J. E., Wang, X., Pisters, P. W., Vauthey, J. N., . . . Katz, M. H. (2012). Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford), 14(6), 365-372. https://doi.org/10.1111/j.1477-2574.2012.00445.x
Upchurch, E., Ragusa, M., & Cirocchi, R. (2018). Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction. Cochrane Database Syst Rev, 5, CD012506. https://doi.org/10.1002/14651858.CD012506.pub2
Valle, J. W., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., . . . Buchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: ongoing lessons from the ESPAC-3 study. J Clin Oncol, 32(6), 504-512. https://doi.org/10.1200/JCO.2013.50.7657
van der Gaag, N. A., Rauws, E. A., van Eijck, C. H., Bruno, M. J., van der Harst, E., Kubben, F. J., . . . Gouma, D. J. (2010). Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med, 362(2), 129-137. https://doi.org/10.1056/NEJMoa0903230
van Heek, N. T., Kuhlmann, K. F., Scholten, R. J., de Castro, S. M., Busch, O., Rvan Gulik, T. M., . . . Gouma, D. J. (2005). Hospital volume and mortality after pancreatic resection: a systematic review and an evaluation of intervention in the Netherlands. Ann Surg, 242(6), 781-788.
van Hilst, J., de Rooij, T., Klompmaker, S., Rawashdeh, M., Aleotti, F., Al-Sarireh, B., . . . European Consortium on Minimally Invasive Pancreatic, S. (2019). Minimally Invasive versus Open Distal Pancreatectomy for Ductal Adenocarcinoma (DIPLOMA): A Pan-European Propensity Score Matched Study. Ann Surg, 269(1), 10-17. https://doi.org/10.1097/SLA.0000000000002561
Vashi, P., Popiel, B., Lammersfeld, C., & Gupta, D. (2015). Outcomes of systematic nutritional assessment and medical nutrition therapy in pancreatic cancer. Pancreas, 44(5), 750-755. https://doi.org/10.1097/mpa.0000000000000336
Verbeke, C. (2016). Morphological heterogeneity in ductal adenocarcinoma of the pancreas - Does it matter? Pancreatology, 16(3), 295-301. https://doi.org/10.1016/j.pan.2016.02.004
Verbeke, C., Brosens, L., Campbell, F., Del Chiaro, M., Esposito, I., Feakins, R. M., . . . Washington, K. (2020). Carcinoma of the Exocrine Pancreas Histopathology Reporting Guide. International Collaboration on Cancer Reporting; Sydney, Australia. . http://www.iccr-cancer.org/datasets/published-datasets/digestive-tract/pancreas
Verbeke, C., Haberle, L., Lenggenhager, D., & Esposito, I. (2018). Pathology assessment of pancreatic cancer following neoadjuvant treatment: Time to move on. Pancreatology. https://doi.org/10.1016/j.pan.2018.04.010
Verbeke, C. S. (2013). Resection margins in pancreatic cancer. Surg Clin North Am, 93(3), 647-662. https://doi.org/10.1016/j.suc.2013.02.008
Verbeke, C. S., & Gladhaug, I. P. (2012). Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg, 99(8), 1036-1049.
Verbeke, C. S., & Gladhaug, I. P. (Under publisering 2016). Dissection of pancreatic specimens. Surg Pathol Clin.
Versteijne, E., Suker, M., Groothuis, K., Akkermans-Vogelaar, J. M., Besselink, M. G., Bonsing, B. A., . . . Dutch Pancreatic Cancer, G. (2020). Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial. J Clin Oncol, 38(16), 1763-1773. https://doi.org/10.1200/JCO.19.02274
Versteijne, E., Vogel, J. A., Besselink, M. G., Busch, O. R. C., Wilmink, J. W., Daams, J. G., . . . Dutch Pancreatic Cancer, G. (2018). Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg, 105(8), 946-958. https://doi.org/10.1002/bjs.10870
Vincent, A., Herman, J., Schulick, R., Hruban, R. H., & Goggins, M. (2011). Pancreatic cancer. Lancet, 378(9791), 607-620.
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., . . . Renschler, M. F. (2013). Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med, 369(18), 1691-1703.
Vrieling, A., Bueno-de-Mesquita, H. B., Boshuizen, H. C., Michaud, D. S., Severinsen, M. T., Overvad, K., . . . Riboli, E. (2010). Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer, 126(10), 2394-2403. https://doi.org/10.1002/ijc.24907
Walma, M. S., Brada, L. J., Patuleia, S. I. S., Blomjous, J. G., Bollen, T. L., Bosscha, K., . . . Dutch Pancreatic Cancer, G. (2020). Treatment strategies and clinical outcomes in consecutive patients with locally advanced pancreatic cancer: A multicenter prospective cohort. Eur J Surg Oncol. https://doi.org/10.1016/j.ejso.2020.11.137
Wang, F., Arianayagam, R., Gill, A., Puttaswamy, V., Neale, M., Gananadha, S., . . . Samra, J. S. (2012). Grafts for mesenterico-portal vein resections can be avoided during pancreatoduodenectomy. J Am Coll Surg, 215(4), 569-579. https://doi.org/10.1016/j.jamcollsurg.2012.05.034
Warshaw, A. L., Lillemoe, K. D., & Fernandez-Del Castillo, C. (2012). Pancreatic surgery for adenocarcinoma. Curr Opin Gastroenterol, 28(5), 488-493. https://doi.org/10.1097/MOG.0b013e3283567f2c
Westgaard, A., Laronningen, S., Mellem, C., Eide, T. J., Clausen, O. P., Moller, B., & Gladhaug, I. P. (2009). Are survival predictions reliable? Hospital volume versus standardisation of histopathologic reporting for accuracy of survival estimates after pancreatoduodenectomy for adenocarcinoma. Eur J Cancer, 45(16), 2850-2859.
Whipple, A. O., Parsons, W. B., & Mullins, C. R. (1935). Treatment of Carcinoma of the Ampulla of Vater. Ann Surg, 102(4), 763-779.
Williamsson, C., Wennerblom, J., Tingstedt, B., & Jonsson, C. (2016). A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer. HPB (Oxford), 18(1), 107-112. https://doi.org/10.1016/j.hpb.2015.08.009
Winter, J. M., Tang, L. H., Klimstra, D. S., Brennan, M. F., Brody, J. R., Rocha, F. G., . . . Allen, P. J. (2012). A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers. PLoS One, 7(7), e40157. https://doi.org/10.1371/journal.pone.0040157
Wong, J. C., & Raman, S. (2010). Surgical resectability of pancreatic adenocarcinoma: CTA. Abdom Imaging, 35(4), 471-480. https://doi.org/10.1007/s00261-009-9539-2
Worni, M., Castleberry, A. W., Clary, B. M., Gloor, B., Carvalho, E., Jacobs, D. O., . . . White, R. R. (2013). Concomitant Vascular Reconstruction During Pancreatectomy for Malignant Disease: A Propensity Score-Adjusted, Population-Based Trend Analysis Involving 10 206 Patients. JAMA Surg, 148, 331-338. https://doi.org/10.1001/jamasurg.2013.1058
Xue, Y., Vanoli, A., Balci, S., Reid, M. M., Saka, B., Bagci, P., . . . Adsay, V. (2017). Non-ampullary-duodenal carcinomas: clinicopathologic analysis of 47 cases and comparison with ampullary and pancreatic adenocarcinomas. Mod Pathol, 30(2), 255-266. https://doi.org/10.1038/modpathol.2016.174
Yamasaki, S., Suda, K., Nobukawa, B., & Sonoue, H. (2002). Intraductal spread of pancreatic cancer. Clinicopathologic study of 54 pancreatectomized patients. Pancreatology, 2(4), 407-412. https://doi.org/10.1159/000065089
Yamauchi, F. I., Ortega, C. D., Blasbalg, R., Rocha, M. S., Jukemura, J., & Cerri, G. G. (2012). Multidetector CT evaluation of the postoperative pancreas. Radiographics, 32(3), 743-764. https://doi.org/10.1148/rg.323105121
Yavuzsen, T., Davis, M. P., Walsh, D., LeGrand, S., & Lagman, R. (2005). Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol, 23(33), 8500-8511.
Yin, Q., Zou, X., Zai, X., Wu, Z., Wu, Q., Jiang, X., . . . Miao, F. (2015). Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode. Eur J Radiol, 84(12), 2470-2476. https://doi.org/10.1016/j.ejrad.2015.09.023
Zhao, W. Y., Luo, M., Sun, Y. W., Xu, Q., Chen, W., Zhao, G., & Wu, Z. Y. (2009). Computed tomography in diagnosing vascular invasion in pancreatic and periampullary cancers: a systematic review and meta-analysis. Hepatobiliary Pancreat Dis Int, 8(5), 457-464.
Zhou, Y., Zhang, Z., Liu, Y., Li, B., & Xu, D. (2012). Pancreatectomy combined with superior mesenteric vein-portal vein resection for pancreatic cancer: a meta-analysis. World J Surg, 36(4), 884-891. https://doi.org/10.1007/s00268-012-1461-z